valganciclovir has been researched along with Infant--Premature--Diseases* in 3 studies
3 other study(ies) available for valganciclovir and Infant--Premature--Diseases
| Article | Year |
|---|---|
Persistent intestinal bleeding due to severe CMV-related thrombocytopenia in a preterm newborn.
The optimal threshold for neonatal platelet transfusions in sick newborns is still uncertain. We report a congenital cytomegalovirus (CMV) infection in a premature neonate with severe thrombocytopenia who subsequently presented with necrotizing enterocolitis and intestinal bleeding. The baby recovered after platelet transfusions were discontinued and the therapy was switched from intravenous ganciclovir to oral valganciclovir. We discuss both measures, speculating on the key role of platelet transfusions. Topics: Antiviral Agents; Cesarean Section; Cytomegalovirus Infections; Enterocolitis, Necrotizing; Female; Ganciclovir; Gastrointestinal Hemorrhage; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Platelet Transfusion; Thrombocytopenia; Valganciclovir | 2018 |
[Valganciclovir treatment of neonatal cytomegalovirus induced hepatitis].
Topics: Antiviral Agents; Cytomegalovirus Infections; Ganciclovir; Hepatitis, Viral, Human; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Valganciclovir | 2009 |
Oral Valganciclovir treatment in a CMV congenital infected infant with sensorineural hearing loss (SNHL) first detected at 4 months of age.
Topics: Administration, Oral; Antiviral Agents; Child, Preschool; Cytomegalovirus Infections; Follow-Up Studies; Ganciclovir; Hearing Loss, Sensorineural; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Long-Term Care; Male; Neonatal Screening; Off-Label Use; Valganciclovir | 2009 |